Benefit Investigation

Benefit Investigation for Specialty
& Infusion Therapy

Medical-vs-pharmacy benefit determination resolved before the first claim. Coverage discovery, plan rules, formulary status, and out-of-pocket exposure clarified upstream so therapy starts without delay and claims route correctly the first time.

< 4 HR

Turnaround

99%+

Routing Accuracy

MEDICAL +

Pharmacy Benefit

The Reality

Why Benefit Investigation Decides Specialty Pharmacy Economics?

Split-Benefit Complexity

A single specialty therapy can be covered under medical benefit, pharmacy benefit, or both — and the rules vary by drug, by plan, and even by site of service. Mis-routing one claim on biologics or oncology orals can mean $10,000 to $40,000 in lost revenue and a 90-day recovery cycle.

Plan Document Variability

Plan documents on specialty therapy run hundreds of pages with exception clauses, site-of-service differentials, and step-therapy requirements buried in fine print. Without trained benefit investigators, the wrong routing decision feels like the right one until the denial arrives.

Site of Service Rules

Infusion drugs administered in physician offices may route differently than the same drug administered in home infusion or ambulatory infusion center. Each site has different coverage logic, prior auth pathways, and reimbursement economics.

Out-of-Pocket Surprise Risk

Patients facing five-figure out-of-pocket exposure on specialty therapy abandon treatment at rates above 30% when costs surprise them at the pharmacy counter. Without benefit investigation that includes patient cost estimation, abandonment becomes routine.

Manufacturer & Foundation Coordination

Benefit investigation triggers downstream workflows: hub enrollment, copay assistance application, manufacturer foundation eligibility. A benefit investigation that doesn't initiate these workflows leaves money and patient access on the table.

Speed-to-Therapy Pressure

Every day between prescription and first fill costs revenue and risks abandonment. Benefit investigation that takes 48–72 hours is a barrier to therapy start. AnnexMed delivers under 4 hours for most therapies.

Recent Client Results

Proof From The Field

A regional specialty pharmacy reduced average benefit investigation turnaround from 36 hours to under 4 hours within 60 days of go-live, eliminating the most common cause of therapy delay. A 15-chair ambulatory infusion center improved medical vs. pharmacy benefit routing accuracy from 87% to 99.4%, recovering approximately $620,000 in previously misrouted infusion claims within six months. A home infusion provider serving 14 territories reduced therapy abandonment rate from 22% to 9% by integrating benefit investigation with same-day patient cost counseling.

< 4 hrs

Standard Benefit Investigation Turnaround

99%+

Medical vs. Pharmacy Routing Accuracy

< 9%

Patient Therapy Abandonment Rate

How we support you

End-to-End Benefit Investigation

AnnexMed delivers benefit investigation as a three-stage operation — discovery, determination, and downstream activation — so specialty therapy starts with the right coverage routing, the right patient financial expectations, and the right hub program enrollment already in motion.

Discovery

Coverage and eligibility data gathering

Determination

Routing and financial clarity

Activation

Triggering downstream workflows

Financial impact and performance

What These Improvements Mean in Dollars?

For a specialty pharmacy with $40M–$80M annual revenue, accurate benefit investigation drives $800K–$2.5M+ in annual recovered revenue and prevented abandonment. Most specialty pharmacies see measurable financial impact within the first 60 days.

Improvement Area

Estimated Annual Impact

Medical vs. Pharmacy Routing Recovery

$300K – $1.2M annually in correctly routed claims

Therapy Abandonment Reduction (22% → 9%)

$400K – $1.5M annually in retained therapy revenue

Site of Service Optimization

$150K – $500K annually in higher-reimbursement routing

Hub Program & Copay Enrollment Lift

$200K – $700K annually in patient assistance captured

Speed-to-Therapy Improvement (36 hr → 4 hr)

$100K – $400K in prevented delay-driven loss

First-Pass Claim Routing Accuracy

$250K – $800K in rework prevention and clean claim lift

Performance Targets vs. Industry Benchmark

KPIs we hold ourselves accountable to — tracked in real time through your operational dashboards:

Performance Metric

Industry Benchmark

AnnexMed Target

Benefit Investigation Turnaround

Industry avg: 24–72 hours

< 4 hours

Medical vs. Pharmacy Routing Accuracy

Industry avg: 86–92%

99%+

First-Fill Therapy Start Rate

Industry avg: 72–80%

94%+

Patient Abandonment Rate

Specialty avg: 22–30%

< 9%

Hub Enrollment Initiation Rate

Industry avg: 65–78%

98%+

Out-of-Pocket Estimation Accuracy

Industry avg: ±20–30%

±5%

Why Annexmed

In-House vs. AnnexMed Partnership

Benefit investigation is where most specialty pharmacy revenue gets won or lost. Here’s how AnnexMed compares to typical in-house or generalist billing operations:

In-House / Traditional

AnnexMed Partnership

Turnaround Time

24–72 hours, longer for complex plans

< 4 hours for most therapies

Routing Accuracy

86–92%, errors discovered post-denial

99%+, routing decision documented upstream

Patient Cost Estimation

Often skipped; patients surprised at counter

Estimated within ±5% before therapy start

Hub Enrollment Trigger

Manual handoff, often delayed or missed

Auto-initiated during benefit investigation

Site of Service Analysis

Defaulted to standard site

Economic comparison across eligible sites

Documentation Trail

Sparse, hard to audit

Full rationale documented in patient record

Specialty Therapy Knowledge

Generalists across all therapy classes

Therapy-trained specialists (oncology, rare disease, biologics)

Cost to Operate

$85K–$115K per FTE loaded

30–40% lower with no recruiting or training overhead

Real cost example: Mid-size specialty pharmacy with $60M annual revenue

In-House: $640,000 annual cost (5.5 FTE benefit investigators + supervision + software access) + estimated $1.4M annual exposure (misrouted claims, abandonment, missed hub enrollment). AnnexMed: $390,000 annual partnership fee + projected $2.1M annual financial benefit (recovered routing, abandonment reduction, hub program lift) = net annual financial benefit of approximately +$1.7M per year.

Technology

Powered by proprietary AI & analytics

AnnexMed’s technology stack was built for payer-specific operational demands, not adapted from provider-side billing tools. Risk adjustment accuracy, payment integrity, and credentialing compliance each require different data models, workflow logic, and reporting architectures than provider RCM. Our platform reflects that.

AI Agents & Automation

AI Agents & Intelligent Automation deploys autonomous AI agents across the full revenue cycle, automating eligibility verification, prior authorization, claims processing, payment posting, and denial management at hospital scale and speed.

Data & Analytics Platform

Data & Analytics Platform delivers real-time Power BI dashboards built for hospital executive visibility, including system-wide KPIs, service line performance, payer analysis, productivity, financial forecasting, and national benchmarking insights.

Intelligent AR Management

Intelligent AR Management handles A/R follow-up at hospital scale with intelligent worklists prioritized by dollar value and aging, payer-specific follow-up rules, automated escalation for high-value accounts, and full accountability for every claim.

Computer Assisted Coding

Computer Assisted Coding orchestrates hospital coding operation, intelligent chart assignment by service line, TAT tracking with SLA monitoring, quality audits with accuracy scoring, and coder performance management at enterprise scale.

Together, these platforms create a fully instrumented RCM operation where nothing falls through the cracks. You don’t interact with these systems directly, but the results they enable show up directly in your financial performance.

Ready to Make Benefit Investigation Your Competitive Edge?

Most specialty pharmacies identify $500K–$1.5M in recoverable annual revenue from benefit investigation improvements in their first assessment. Schedule a no-obligation Benefit Investigation Audit.

Trusted by 100+ Healthcare Providers | AAPC, AHIMA & AAHAM Certified | SOC 2 Type II | HIPAA Compliant

Payer client outcomes

AnnexMed delivers measurable financial impact within the first 60 to 90 days of engagement. The following represent outcomes from active payer partnerships:

$15M–$40M

Risk
Adjustment

$18M–$50M

Payment
Integrity

6 Weeks

Credentialing Clearance

$15M–$50M+

Revenue
Impact

Case Studies

See the impact we deliver

Discover how AnnexMed reduces denials, accelerates reimbursements, and strengthens financial performance. Backed by measurable outcomes and proven RCM expertise, we deliver operational excellence, revenue stability, and sustainable growth you can trust.

Client Voices

See how our clients succeed

Hear from organizations that trust AnnexMed to reduce denials, accelerate reimbursements, and strengthen cash flow. Our expert support delivers measurable performance gains, operational efficiency, financial stability, and scalable growth.

Claims adjudication backlogs were delaying provider payments and increasing complaint volumes. AnnexMed took over processing, cleared the backlog in 30 days, and improved turnaround by 45%. Provider satisfaction scores climbed significantly, dispute volumes dropped, and our network relationships strengthened significantly.

Dr. Richard Calloway

Horizon Health Plan

Our payer operations team was overwhelmed with member inquiries, provider disputes, and claims rework. AnnexMed brought dedicated support that handled every function with accuracy and speed. Processing errors dropped by 60%, provider abrasion decreased, and our operational costs came down by nearly a third.

Dr. Priya Menon

Crestview Insurance Partners

Managing claims accuracy, provider data, and member support internally was draining our resources. AnnexMed streamlined our payer operations end to end. Claims processing improved, provider onboarding accelerated, and our administrative burden reduced dramatically. They understand payer complexity like no other partner.

Laura Simmons

Meridian Managed Care

Proven RCM expertise. Delivered at scale.

For over 20 years, AnnexMed has delivered RCM solutions nationwide, combining expert billing, coding, and AR support to drive measurable results and growth.

Hospital Solutions

RCM Partners Solutions

Practice Solutions

Payer Solutions

Pharmacy Solutions

Payer Services

Patient Access Services

Medical Coding Services

Revenue Cycle Operations

Revenue Recovery Solutions

Payer Services

Dental Services

Business Intelligence

Benefit Investigation